Longeveron (LGVN) Current Deferred Revenue (2021 - 2026)
Longeveron (LGVN) recorded quarterly Current Deferred Revenue of $102000.0 in Q1 2026, up 155.0% quarter-over-quarter from $40000.0 in Q4 2025.
Longeveron (LGVN) Current Deferred Revenue (2021 - 2026) Analysis & Trends
Longeveron's Current Deferred Revenue history runs 6 years deep, the most recent figure standing at $102000.0 for Q1 2026.
- In Q1 2026, Current Deferred Revenue changed N/A year-over-year to $102000.0; the TTM figure through Mar 2026 stood at $102000.0 (changed N/A YoY), while the FY2025 annual figure was $40000.0, changed 0.0% from the prior year.
- Current Deferred Revenue was $102000.0 for Q1 2026 at Longeveron, up from $40000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $506000.0 in Q4 2022 to a low of $0.1 in Q2 2024.
- Historically, Current Deferred Revenue has averaged $97333.3 across 5 years, with a median of $70000.0 in 2022.
- The sharpest annual moves came in 2024 and 2025: Current Deferred Revenue tumbled 100.0% in 2024, then soared 39999900.0% in 2025.
- A 5-year view of Current Deferred Revenue shows it stood at $506000.0 in 2022, then plunged by 80.24% to $100000.0 in 2023, then tumbled by 60.0% to $40000.0 in 2024, then changed by 0.0% to $40000.0 in 2025, then jumped by 155.0% to $102000.0 in 2026.
- The last three Current Deferred Revenue figures came in at $102000.0 (Q1 2026), $40000.0 (Q4 2025), and $40000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Longeveron | 20.35 Bn | 20.33 Bn | 264,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 102,000.00 |
| Dec 31, 2025 | 40,000.00 |
| Sep 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 40,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Sep 30, 2024 | 0.10 |
| Jun 30, 2024 | 0.10 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Dec 31, 2022 | 506,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Dec 31, 2021 | 199,000.00 |